Cinética da absorção de cálcio na presença de magnésio em células foliares de cafeeiro (Coffea arabica L. cv. 'Mundo Novo')

This study based on LINEWEAVER & BURK's (1934) equation was made to verify both competitive or not effect of Mg2_f in absorption of Ca2+ ion. Solution of CaCl2 was traced with 45Ca. Calcium in different concentration was added to excised leaf tissue of Coffee-tree (Coffea arabica L.) in presence or not of magnesium, according to SMITH & EPSTEIN's (1964a.; 1964b.) technique. Special conduction in statistics was applied. Magnesium ion compete with calcium ion to active centers of metabolism transport.No trabalho apresentado, estudou-se a cinética de absorção de íons, baseado na equação de LINEWEAVER & bURk (1934). o estudo visou verificar o efeito competitivo ou não do íon Mg²+ na absorção do íon Ca²+. Para facilidade do estudo, soluções de CaCl2 marcadas com 45Ca foram administradas em diferentes concentrações à tecidos foliares de café (Coffea arabica L., cv. 'Mundo Novo'), em solução contendo ou não uma concentração conhecida de MgCl2 segundo a técnica de SMITH & EPSTEIN (1964a e 1964b). São apresentados também cálculos estatísticos, considerados inéditos na aplicação do presente estudo. Conclue-se que há inibição competitiva devida ao íon Mg²+ pelos centros ativos dos carregadores

Tracking the antibody immunome in sporadic colorectal cancer by using antigen self-assembled protein arrays

© 2021 by the authors.Sporadic Colorectal Cancer (sCRC) is the third leading cause of cancer death in the Western world, and the sCRC patients presenting with synchronic metastasis have the poorest prognosis. Genetic alterations accumulated in sCRC tumor cells translate into mutated proteins and/or abnormal protein expression levels, which contribute to the development of sCRC. Then, the tumor-associated proteins (TAAs) might induce the production of auto-antibodies (aAb) via humoral immune response. Here, Nucleic Acid Programmable Protein Arrays (NAPPArray) are employed to identify aAb in plasma samples from a set of 50 sCRC patients compared to seven healthy donors. Our goal was to establish a systematic workflow based on NAPPArray to define differential aAb profiles between healthy individuals and sCRC patients as well as between non-metastatic (n = 38) and metastatic (n = 12) sCRC, in order to gain insight into the role of the humoral immune system in controlling the development and progression of sCRC. Our results showed aAb profile based on 141 TAA including TAAs associated with biological cellular processes altered in genesis and progress of sCRC (e.g., FSCN1, VTI2 and RPS28) that discriminated healthy donors vs. sCRC patients. In addition, the potential capacity of discrimination (between non-metastatic vs. metastatic sCRC) of 7 TAAs (USP5, ML4, MARCKSL1, CKMT1B, HMOX2, VTI2, TP53) have been analyzed individually in an independent cohort of sCRC patients, where two of them (VTI2 and TP53) were validated (AUC ~75%). In turn, these findings provided novel insights into the immunome of sCRC, in combination with transcriptomics profiles and protein antigenicity characterizations, wich might lead to the identification of novel sCRC biomarkers that might be of clinical utility for early diagnosis of the tumor. These results explore the immunomic analysis as potent source for biomarkers with diagnostic and prognostic value in CRC. Additional prospective studies in larger series of patients are required to confirm the clinical utility of these novel sCRC immunomic biomarkers.We gratefully acknowledge financial support from the Spanish Health Institute Carlos III (ISCIII) for the grants: FIS PI14/01538, FIS PI17/01930 and CB16/12/00400. We also acknowledge Fondos FEDER (EU) “Una manera de hacer Europa” and Junta Castilla-León (COVID19 grant COV20EDU/00187). Fundación Solórzano FS/38-2017. The Proteomics Unit belongs to ProteoRed, PRB3-ISCIII, supported by grant PT17/0019/0023, of the PE I + D + I 2017-2020, funded by ISCIII and FEDER. CNPq-National Council for Scientific and Technological Development (Brazil) (306258/2019-6) and FAPERJ-Foundation for Research Support of Rio de Janeiro State for the financial support (E-26/201.670/2017 and 210.379/2018). M. González-González is supported by MINECOPTA2019-017870-I.A. Landeira-Viñuela is supported by VIII Centenario-USAL PhD Program. P.J.-V. is supported by JCYL PhD Program and scholarship JCYL-EDU/601/2020. P.D. and E.B. are supported by a JCYL-EDU/346/2013 Ph.D. scholarship